Physician profile
Andria Walker
NPI 1962020701
$414.61
in general payments reported to CMS, 2019-2025
12 companies · $17.42 in 2025
The $17.42 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.84 · 2022: $52.95 · 2023: $331 · 2025: $17.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $92.91 | 2023-2025 | Vpriv, Elaprase, Cuvitru |
| Tersera Therapeutics LLC | $65.16 | 2022-2023 | Quzyttir |
| Janssen Biotech, INC. | $43.17 | 2023 | Tremfya, Simponi Aria |
| Pharmacosmos Therapeutics INC. | $33.86 | 2023 | Monoferric |
| Biogen, INC. | $30.75 | 2023 | |
| Genzyme Corporation | $30.00 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $24.59 | 2023 | Saphnelo |
| Lundbeck LLC | $23.29 | 2023 | Vyepti |
| Aurinia Pharma U.S., INC. | $21.65 | 2023 | Lupkynis |
| Horizon Therapeutics Plc | $18.85 | 2022 | |
| Radius Health, INC. | $17.54 | 2023 | Tymlos |
| Amgen INC. | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andria Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.